As HDAC inhibition increased IL-13Rα2 expression in IL-13Rα2-negative but not in normal cell lines, we examined whether HDAC inhibition enhanced the anti-cancer effect of IL-13-PE in IL-13Rα2-negative pancreatic cancer cell lines. This evidence concerns the gene IL13RA2 and familial pancreatic carcinoma.